Secondary prevention of Alzheimer’s dementia: neuroimaging contributions

by Mara ten Kate, Silvia Ingala, Adam J. Schwarz, Nick C. Fox, Gaël Chételat, Bart N. M. van Berckel, Michael Ewers, Christopher Foley, Juan Domingo Gispert, Derek Hill, Michael C. Irizarry, Adriaan A. Lammertsma, José Luis Molinuevo, Craig Ritchie, Philip Scheltens, Mark E. Schmidt, Pieter Jelle Visser, Adam Waldman, Joanna Wardlaw, Sven Haller, Frederik Barkhof
Published 2018-10-01

The predictive value of normal EEGs in dementia due to Alzheimer’s disease

by Casper T. Briels, Cornelis J. Stam, Philip Scheltens, Alida A. Gouw
Published 2021-05-01

Evaluating combinations of diagnostic tests to discriminate different dementia types

by Marie Bruun, Hanneke F.M. Rhodius‐Meester, Juha Koikkalainen, Marta Baroni, Le Gjerum, Afina W. Lemstra, Frederik Barkhof, Anne M. Remes, Timo Urhemaa, Antti Tolonen, Daniel Rueckert, Mark vanGils, Kristian S. Frederiksen, Gunhild Waldemar, Philip Scheltens, Patrizia Mecocci, Hilkka Soininen, Jyrki Lötjönen, Steen G. Hasselbalch, Wiesje M. van derFlier
Published 2018-01-01

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease

by Meenakshi Dauwan, Jessica J. van derZande, Edwin vanDellen, Iris E.C. Sommer, Philip Scheltens, Afina W. Lemstra, Cornelis J. Stam
Published 2016-01-01

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

by Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra
Published 2019-10-01

Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease

by Hanneke F. M. Rhodius-Meester, Hilkka Liedes, Ted Koene, Afina W. Lemstra, Charlotte E. Teunissen, Frederik Barkhof, Philip Scheltens, Mark van Gils, Jyrki Lötjönen, Wiesje M. van der Flier
Published 2018-02-01

EEG Characteristics of Dementia With Lewy Bodies, Alzheimer’s Disease and Mixed Pathology

by Jessica J. van der Zande, Alida A. Gouw, Alida A. Gouw, Inger van Steenoven, Philip Scheltens, Cornelis Jan Stam, Afina W. Lemstra
Published 2018-07-01

Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review

by Hulya Ulugut, Anke A. Dijkstra, Marta Scarioni, Netherlands Brain Bank, Frederik Barkhof, Philip Scheltens, Annemieke J. M. Rozemuller, Yolande A. L. Pijnenburg
Published 2021-08-01

Exercise and Early-Onset Alzheimer’s Disease: Theoretical Considerations

by Astrid M. Hooghiemstra, Laura H.P. Eggermont, Philip Scheltens, Wiesje M. van der Flier, Erik J.A. Scherder
Published 2012-04-01

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

by Mara ten Kate, Frederik Barkhof, Pieter Jelle Visser, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Betty M. Tijms
Published 2017-09-01

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier

by Antti Tolonen, Hanneke F. M. Rhodius-Meester, Marie Bruun, Juha Koikkalainen, Frederik Barkhof, Frederik Barkhof, Afina W. Lemstra, Teddy Koene, Philip Scheltens, Charlotte E. Teunissen, Tong Tong, Ricardo Guerrero, Andreas Schuh, Christian Ledig, Marta Baroni, Daniel Rueckert, Hilkka Soininen, Hilkka Soininen, Anne M. Remes, Anne M. Remes, Gunhild Waldemar, Steen G. Hasselbalch, Patrizia Mecocci, Wiesje M. van der Flier, Wiesje M. van der Flier, Jyrki Lötjönen
Published 2018-04-01

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline

by Ingrid S. van Maurik, Ingrid S. van Maurik, Els D. Bakker, Susanne van den Buuse, Freek Gillissen, Marleen van de Beek, Evelien Lemstra, Arenda Mank, Arenda Mank, Karlijn A. van den Bosch, Mardou van Leeuwenstijn, Femke H. Bouwman, Philip Scheltens, Wiesje M. van der Flier, Wiesje M. van der Flier
Published 2020-10-01

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

by Arno de Wilde, Marieke M. van Buchem, René H. J. Otten, Femke Bouwman, Andrew Stephens, Frederik Barkhof, Philip Scheltens, Wiesje M. van der Flier
Published 2018-07-01

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

by Ananya Chakraborty, Madhurima Chatterjee, Harry Twaalfhoven, Marta Del Campo Milan, Charlotte E. Teunissen, Philip Scheltens, Ruud D. Fontijn, Wiesje M. van Der Flier, Helga E. de Vries
Published 2018-06-01

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia

by Nick vanWijk, Rosalinde E.R. Slot, Flora H. Duits, Marieke Strik, Egbert Biesheuvel, John W.C. Sijben, Marinus A. Blankenstein, Jörgen Bierau, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Published 2017-01-01

Effectiveness of family meetings for family caregivers on delaying time to nursing home placement of dementia patients: a randomized trial.

by Karlijn J Joling, Harm W J van Marwijk, Henriëtte E van der Horst, Philip Scheltens, Peter M van de Ven, Bregje A Appels, Hein P J van Hout
Published 2012-01-01

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

by Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte E. Teunissen, Kaj Blennow
Published 2021-02-01

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

by Lisa Vermunt, Graciela Muniz-Terrera, Lea ter Meulen, Colin Veal, Kaj Blennow, Archie Campbell, Isabelle Carrié, Julien Delrieu, Karine Fauria, Gema Huesa Rodríguez, Silvia Ingala, Natalie Jenkins, José Luis Molinuevo, Pierre-Jean Ousset, David Porteous, Niels D. Prins, Alina Solomon, Brian D. Tom, Henrik Zetterberg, Marissa Zwan, Craig W. Ritchie, Philip Scheltens, Gerald Luscan, Anthony J. Brookes, Pieter Jelle Visser, for the IMI-EPAD collaborators
Published 2020-01-01

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire

by Roos J. Jutten, Carel F.W. Peeters, Sophie M.J. Leijdesdorff, Pieter Jelle Visser, Andrea B. Maier, Caroline B. Terwee, Philip Scheltens, Sietske A.M. Sikkes
Published 2017-01-01

Does a family meetings intervention prevent depression and anxiety in family caregivers of dementia patients? A randomized trial.

by Karlijn J Joling, Harm W J van Marwijk, Filip Smit, Henriëtte E van der Horst, Philip Scheltens, Peter M van de Ven, Mary S Mittelman, Hein P J van Hout
Published 2012-01-01